Leuchte HH - Search Results

1

Inhalation of vasoactive intestinal peptide in pulmonary hypertension.

Leuchte HH, Baezner C, Baumgartner RA, Bevec D, Bacher G, Neurohr C, Behr J. Leuchte HH, et al. Eur Respir J. 2008 Nov;32(5):1289-94. doi: 10.1183/09031936.00050008. Eur Respir J. 2008. PMID: 18978135 Free article.

2

Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics.

Walmrath D, Grimminger F, Pappert D, Knothe C, Obertacke U, Benzing A, Günther A, Schmehl T, Leuchte H, Seeger W. Walmrath D, et al. Eur Respir J. 2002 May;19(5):805-10. doi: 10.1183/09031936.02.00243402. Eur Respir J. 2002. PMID: 12030717 Free article. Clinical Trial.

3

[Acute pulmonary embolism emergency. Confirming diagnosis, administering heparin, begin thrombolysis].

Leuchte HH, Behr J. Leuchte HH, et al. MMW Fortschr Med. 2003 May 15;145(20):39-43. MMW Fortschr Med. 2003. PMID: 12822229 German.

4

Glutamate-cysteine ligase modulatory subunit in BAL alveolar macrophages of healthy smokers.

Neurohr C, Lenz AG, Ding I, Leuchte H, Kolbe T, Behr J. Neurohr C, et al. Eur Respir J. 2003 Jul;22(1):82-7. doi: 10.1183/09031936.03.00080403. Eur Respir J. 2003. PMID: 12882455 Free article.

5

Zardaverine and aerosolised iloprost in a model of acute respiratory failure.

Schermuly RT, Leuchte H, Ghofrani HA, Weissmann N, Rose F, Kohstall M, Olschewski H, Schudt C, Grimminger F, Seeger W, Walmrath D. Schermuly RT, et al. Eur Respir J. 2003 Aug;22(2):342-7. doi: 10.1183/09031936.03.00093802. Eur Respir J. 2003. PMID: 12952271 Free article.

6

Treatment of severe pulmonary hypertension with inhaled iloprost.

Leuchte HH, Baumgartner RA, Behr J. Leuchte HH, et al. Ann Intern Med. 2003 Aug 19;139(4):306. doi: 10.7326/0003-4819-139-4-200308190-00025. Ann Intern Med. 2003. PMID: 12965995 No abstract available.

7

Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.

Leuchte HH, Schwaiblmair M, Baumgartner RA, Neurohr CF, Kolbe T, Behr J. Leuchte HH, et al. Chest. 2004 Feb;125(2):580-6. doi: 10.1378/chest.125.2.580. Chest. 2004. PMID: 14769741

8

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.

Leuchte HH, Holzapfel M, Baumgartner RA, Ding I, Neurohr C, Vogeser M, Kolbe T, Schwaiblmair M, Behr J. Leuchte HH, et al. J Am Coll Cardiol. 2004 Mar 3;43(5):764-70. doi: 10.1016/j.jacc.2003.09.051. J Am Coll Cardiol. 2004. PMID: 14998614 Free article.

9

Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension.

Leuchte HH, Neurohr C, Baumgartner R, Holzapfel M, Giehrl W, Vogeser M, Behr J. Leuchte HH, et al. Am J Respir Crit Care Med. 2004 Aug 15;170(4):360-5. doi: 10.1164/rccm.200308-1142OC. Epub 2004 Apr 15. Am J Respir Crit Care Med. 2004. PMID: 15087298 Clinical Trial.

10

Iloprost for idiopathic pulmonary arterial hypertension.

Leuchte HH, Behr J. Leuchte HH, et al. Expert Rev Cardiovasc Ther. 2005 Mar;3(2):215-23. doi: 10.1586/14779072.3.2.215. Expert Rev Cardiovasc Ther. 2005. PMID: 15853595 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters